Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intrathecal Morphine Injection Versus Continuous Wound Infiltration After Pancreaticoduodenectomy
Sponsor: Seoul National University Hospital
Summary
This is a prospective randomized open-label noninferiority trial that compares intrathecal morphine injection and continuous wound infiltration after open pancreaticoduodenectomy.
Official title: Effect of Single-Shot Intrathecal Morphine Injection Versus Continuous Wound Infiltration on Postoperative Pain After Pancreaticoduodenectomy: a Prospective, Open-Label, Randomized Controlled, Non-Inferiority Trial
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
104
Start Date
2025-01-15
Completion Date
2027-01-07
Last Updated
2025-03-19
Healthy Volunteers
No
Conditions
Interventions
Intrathecal morphine injection
A single dose of intrathecal morphine is administered prior to induction of general anesthesia. The patient is placed in the lateral decubitus position on the bed and a 25 guage quincke spinal needle is inserted intrathecally at the L4/5 median or paramedian approach to administer 0.2 mg of morphine.
Continuous wound infiltration
Prior to closure of the abdominal wall, a catheter is placed in the preperitoneal space lateral to the surgical incision through the tunneler. The catheter is connected to a prepared infusion pump (275 ml of 0.5% ropivacaine, 4 ml/hr/catheter), and the remaining catheter protruding from the abdomen is secured with a catheterization dressing. The preperitoneal catheter is removed in the afternoon of postoperative day 3.
Locations (1)
Seoul National University Hospital
Seoul, Seoul, South Korea